시장보고서
상품코드
1299826

세계의 게노믹스용 인공지능(AI) 시장(2023-2033년)

Artificial Intelligence (AI) in Genomics Market Report 2023-2033

발행일: | 리서치사: Visiongain Reports Ltd. | 페이지 정보: 영문 316 Pages | 배송안내 : 1-2일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 게노믹스용 인공지능(AI) 시장 규모는 2033년까지 38.4%의 CAGR로 성장할 것으로 예상됩니다. 인공지능(AI) 기술을 활용한 게놈에 대한 노력이 증가하면 시장 성장을 촉진할 수 있습니다.

이 보고서는 세계 게노믹스용 인공지능(AI) 시장에 대해 조사했으며, 시장 개요, 시장 분석, 기업 개요 등 종합적인 정보를 제공합니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

  • 주요 조사 결과
  • 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
    • COVID-19의 영향 분석

제4장 게노믹스용 인공지능(AI) 시장 분석 : 제공별

  • 주요 조사 결과
  • 제공 부문 : 시장 매력도 지수
  • 게노믹스용 인공지능(AI) 시장 규모 추정과 예측 : 제공별
  • 소프트웨어
  • 서비스

제5장 게노믹스용 인공지능(AI) 시장 분석 : 기술별

  • 주요 조사 결과
  • 기술 부문 : 시장 매력도 지수
  • 게노믹스용 인공지능(AI) 시장 규모 추정과 예측 : 기술별
  • 머신러닝
  • 컴퓨터 비전

제6장 게노믹스용 인공지능(AI) 시장 분석 : 제공 방법별

  • 주요 조사 결과
  • 제공 방법 부문 : 시장 매력도 지수
  • 게노믹스용 인공지능(AI) 시장 규모 추정과 예측 : 제공 방법별
  • 온프레미스
  • 클라우드 및 웹 기반 모드

제7장 게노믹스용 인공지능(AI) 시장 분석 : 기능별

  • 주요 조사 결과
  • 기능 부문 : 시장 매력도 지수
  • 게노믹스용 인공지능(AI) 시장 규모 추정과 예측 : 기능별
  • 게놈 배열 결정
  • 유전자 편집
  • 임상 워크플로우
  • 발증전 유전자 검사와 예방 의학

제8장 게노믹스용 인공지능(AI) 시장 분석 : 용도별

  • 주요 조사 결과
  • 용도 부문 : 시장 매력도 지수
  • 게노믹스용 인공지능(AI) 시장 규모 추정과 예측 : 용도별
  • Drug Discovery & Development
  • 정밀의료
  • 진단
  • 농업·동물 연구
  • 기타

제9장 게노믹스용 인공지능(AI) 시장 분석 : 최종사용자별

  • 주요 조사 결과
  • 최종사용자 부문 : 시장 매력도 지수
  • 게노믹스용 인공지능(AI) 시장 규모 추정과 예측 : 최종사용자별
  • 제약 기업 및 바이오테크놀러지 기업
  • 의료기관
  • 연구 센터
  • 학술기관 및 정부기관
  • 기타

제10장 게노믹스용 인공지능(AI) 시장 분석 : 지역별

  • 주요 조사 결과
  • 지역 시장 규모 추정과 예측

제11장 북미의 게노믹스용 인공지능(AI) 시장

제12장 유럽의 게노믹스용 인공지능(AI) 시장

제13장 아시아태평양의 게노믹스용 인공지능(AI) 시장

제14장 라틴아메리카의 게노믹스용 인공지능(AI) 시장

제15장 중동 및 아프리카의 게노믹스용 인공지능(AI) 시장

제16장 기업 개요

  • 경쟁 상황(2022년)
  • 전략 전망
  • IBM
  • MICROSOFT CORPORATION
  • NVIDIA CORPORATION
  • DEEP GENOMICS INCORPORATED
  • FABRIC GENOMICS, INC.
  • DATA4CURE, INC.
  • PREDICTIVE ONCOLOGY INC.
  • EMEDGENE TECHNOLOGIES LTD
  • CONGENICA LTD.
  • SOPHIA GENETICS SA
  • ILLUMINA INC.
  • BenevolentAI Limited.
  • Freenome Holdings, Inc
  • Verge Genomics

제17장 결론과 추천사항

  • 결론
  • 시장 진출 기업을 위한 추천사항
ksm 23.07.10

The global Artificial Intelligence (AI) in Genomics market is projected to grow at a CAGR of 38.4% by 2033.

“The Artificial Intelligence (AI) in Genomics Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to understand the industry and its underlying dynamics better. It will be useful for companies that want to expand into different industries or their existing operations in a new region.

Increasing Genomic Initiatives Using AI Techniques Driving Market Growth

Using methods ranging from genotyping to whole genome sequencing, 38 million genomes have been examined, and 52 million were anticipated to be done by 2025. Healthcare stakeholders can benefit from genomic initiatives by developing companion diagnostics to personalize medicine treatment, identifying genetic variants that increase disease risk, diagnosing patients earlier, and preventing disease. Genomic initiatives can also hasten new medicines' discovery, repurposing, and clinical development.

The Shortage of Skilled Personnel and the Concerns Associated with Data Privacy to Hamper Industry Growth

AI is a complex field that requires a highly skilled workforce to develop, implement, and maintain AI solutions. The healthcare industry, in particular, has unique data privacy and regulatory challenges that require a deep understanding of both healthcare and AI. Genomics is a rapidly changing field that analyses and interprets vast amounts of genetic data to gain insights into diseases, drug development, and personalized medicine. AI plays a crucial role in processing and analyzing this data, but its implementation requires specialized knowledge and skills. As a result, the demand for AI professionals in genomics has been growing as the field progresses, but the supply of qualified individuals has not kept pace. This scarcity limits the number of experts available to develop and apply AI algorithms and tools in genomics research, clinical settings, and pharmaceutical companies. The shortage of AI talent has led to increased competition for skilled professionals, resulting in higher salaries and more challenging recruitment efforts. According to a recent IBM Institute for Business Value report, around 120 million people in the world's twelve largest economies, including 11.5 million in the U.S., will require retraining or reskilling within the next three years due to AI and intelligent automation. To address this challenge, some organizations invest in AI education and training programs to build a pipeline of skilled AI professionals. Others are partnering with universities and research institutions to develop AI talent and encourage the development of AI solutions for genomics. Additionally, some companies are leveraging automated machine learning (AutoML) tools and platforms to reduce the need for highly skilled AI professionals.

Furthermore, integrating AI in the genomics sector often involves the analysis of large-scale datasets, including genomic sequences, clinical records, and other health-related information. Integrating these diverse data sources can lead to valuable insights and advancements in personalized medicine. However, it introduces challenges related to data privacy.

Therefore, addressing these challenges requires robust data protection measures, privacy regulations, technological advancements, and public awareness efforts to ensure the responsible and secure use of genomic data in AI applications.

What Questions Should You Ask Before Buying a Market Research Report?

  • How is AI in the genomics market evolving?
  • What is driving and restraining AI in the genomics market?
  • How will each AI in Genomics submarket segment grow over the forecast period, and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each AI in Genomics submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading AI in Genomics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033, and which geographical region will lead the market in 2033?
  • Who are the leading players, and what are their prospects over the forecast period?
  • What are the AI in Genomics projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of AI in Genomics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialization to further scale AI in the genomics market?
  • Where is the AI in Genomics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the AI in Genomics market today, and over the next 10 years:

  • Our 316-page report provides 128 tables and 191 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the AI in Genomics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising AI in Genomics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Offering Outlook

  • Software
  • Services

Technology

  • Machine Learning
  • Computer Vision

Delivery Mode

  • On-premises
  • Cloud & Web-Based Mode

Functionality

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflows
  • Predictive Genetic Testing & Preventive Medicine

Application

  • Drug Discovery & Development
  • Precision Medicine
  • Diagnostics
  • Agriculture & Animal Research
  • Other Applications

End-User

  • Pharmaceutical & Biotech Companies
  • Healthcare Providers
  • Research Centers
  • Academic Institutes & Government Organizations
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and xx leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the AI in Genomics Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading Companies and the Potential for market growth:

  • IBM
  • Microsoft Corporation
  • NVIDIA Corporation
  • Deep Genomics Incorporated
  • Fabric Genomics, Inc
  • Data4cure, Inc
  • Predictive Oncology Inc.
  • Emedgene Technologies Ltd
  • Congenica Ltd
  • Sophia Genetics SA
  • Illumina Inc
  • BenevolentAI limited
  • Freenome Holdings, Inc
  • Verge Genomics

Overall world revenue for AI in Genomics Market, 2023 to 2033 in terms of value the market will surpass US$761.1 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the AI in Genomics Market, 2023 to 2033 report help you?

In summary, our 310+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for AI in Genomics Market, 2023 to 2033 Market, with forecasts for Offering, Technology, Delivery Mode, Functionality, Application, End-User, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 16 key national markets - See forecasts for the AI in Genomics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for IBM, Microsoft Corporation, Nvidia Corporation and Deep Genomics Incorporated are some of the major companies involved in the AI in Genomics Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the AI in Genomics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Artificial Intelligence in Genomics Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Adoption of AI in research areas
      • 3.2.1.2 Growing demand for precision medicine
      • 3.2.1.3 Increasing genomic initiatives using AI techniques
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 The shortage of skilled personnel and the concerns associated with data privacy
      • 3.2.2.2 Regulatory Hurdles and ethical considerations
    • 3.2.3 Market Opportunities
      • 3.2.3.1 The emergence of human-aware AI Systems
  • 3.3 COVID-19 Impact Analysis

4 Artificial Intelligence in Genomics Market Analysis by Offering

  • 4.1 Key Findings
  • 4.2 Offering Segment: Market Attractiveness Index
  • 4.3 Artificial Intelligence in Genomics Market Size Estimation and Forecast by Offering
  • 4.4 Software
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Services
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Artificial Intelligence in Genomics Market Analysis by Technology

  • 5.1 Key Findings
  • 5.2 Technology Segment: Market Attractiveness Index
  • 5.3 Artificial Intelligence in Genomics Market Size Estimation and Forecast by Technology
  • 5.4 Machine Learning
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
    • 5.4.3 Machine Learning in Genomics Market Size Estimation and Forecast by Type
  • 5.5 Computer Vision
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Artificial Intelligence in Genomics Market Analysis by Delivery Mode

  • 6.1 Key Findings
  • 6.2 Delivery Mode Segment: Market Attractiveness Index
  • 6.3 Artificial Intelligence in Genomics Market Size Estimation and Forecast by Delivery Mode
  • 6.4 On-premises
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Cloud & Web-Based Mode
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Artificial Intelligence in Genomics Market Analysis by Functionality

  • 7.1 Key Findings
  • 7.2 Functionality Segment: Market Attractiveness Index
  • 7.3 Artificial Intelligence in Genomics Market Size Estimation and Forecast by Functionality
  • 7.4 Genome Sequencing
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Gene Editing
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Clinical Workflows
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)
  • 7.7 Predictive Genetic Testing & Preventive Medicine
    • 7.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.7.2 Market Share by Region, 2023 & 2033 (%)

8 Artificial Intelligence in Genomics Market Analysis by Application

  • 8.1 Key Findings
  • 8.2 Application Segment: Market Attractiveness Index
  • 8.3 Artificial Intelligence in Genomics Market Size Estimation and Forecast by Application
  • 8.4 Drug Discovery & Development
    • 8.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Precision Medicine
    • 8.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Diagnostics
    • 8.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)
  • 8.7 Agriculture & Animal Research
    • 8.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.7.2 Market Share by Region, 2023 & 2033 (%)
  • 8.8 Other Applications
    • 8.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.8.2 Market Share by Region, 2023 & 2033 (%)

9 Artificial Intelligence in Genomics Market Analysis by End-User

  • 9.1 Key Findings
  • 9.2 End-User Segment: Market Attractiveness Index
  • 9.3 Artificial Intelligence in Genomics Market Size Estimation and Forecast by End-User
  • 9.4 Pharmaceutical & Biotech Companies
    • 9.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.4.2 Market Share by Region, 2023 & 2033 (%)
  • 9.5 Healthcare Providers
    • 9.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.5.2 Market Share by Region, 2023 & 2033 (%)
  • 9.6 Research Centers
    • 9.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.6.2 Market Share by Region, 2023 & 2033 (%)
  • 9.7 Academic Institutes & Government Organizations
    • 9.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.7.2 Market Share by Region, 2023 & 2033 (%)
  • 9.8 Other End-Users
    • 9.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.8.2 Market Share by Region, 2023 & 2033 (%)

10 Artificial Intelligence in Genomics Market Analysis by Region

  • 10.1 Key Findings
  • 10.2 Regional Market Size Estimation and Forecast

11 North America Artificial Intelligence in Genomics Market Analysis

  • 11.1 Key Findings
  • 11.2 North America Artificial Intelligence in Genomics Market Attractiveness Index
  • 11.3 North America Artificial Intelligence in Genomics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 11.4 North America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Country
  • 11.5 North America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Offering
  • 11.6 North America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Technology
  • 11.7 North America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Delivery Mode
  • 11.8 North America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Functionality
  • 11.9 North America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Application
  • 11.10 North America Artificial Intelligence in Genomics Market Size Estimation and Forecast by End-User
  • 11.11 U.S. Artificial Intelligence in Genomics Market Analysis
  • 11.12 Canada Artificial Intelligence in Genomics Market Analysis

12 Europe Artificial Intelligence in Genomics Market Analysis

  • 12.1 Key Findings
  • 12.2 Europe Artificial Intelligence in Genomics Market Attractiveness Index
  • 12.3 Europe Artificial Intelligence in Genomics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 Europe Artificial Intelligence in Genomics Market Size Estimation and Forecast by Country
  • 12.5 Europe Artificial Intelligence in Genomics Market Size Estimation and Forecast by Offering
  • 12.6 Europe Artificial Intelligence in Genomics Market Size Estimation and Forecast by Technology
  • 12.7 Europe Artificial Intelligence in Genomics Market Size Estimation and Forecast by Delivery Mode
  • 12.8 Europe Artificial Intelligence in Genomics Market Size Estimation and Forecast by Functionality
  • 12.9 Europe Artificial Intelligence in Genomics Market Size Estimation and Forecast by Application
  • 12.10 Europe Artificial Intelligence in Genomics Market Size Estimation and Forecast by End-User
  • 12.11 Germany Artificial Intelligence in Genomics Market Analysis
  • 12.12 UK Artificial Intelligence in Genomics Market Analysis
  • 12.13 France Artificial Intelligence in Genomics Market Analysis
  • 12.14 Italy Artificial Intelligence in Genomics Market Analysis
  • 12.15 Spain Artificial Intelligence in Genomics Market Analysis
  • 12.16 Rest of Europe Artificial Intelligence in Genomics Market Analysis

13 Asia-Pacific Artificial Intelligence in Genomics Market Analysis

  • 13.1 Key Findings
  • 13.2 Asia-Pacific Artificial Intelligence in Genomics Market Attractiveness Index
  • 13.3 Asia-Pacific Artificial Intelligence in Genomics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 13.4 Asia-Pacific Artificial Intelligence in Genomics Market Size Estimation and Forecast by Country
  • 13.5 Asia-Pacific Artificial Intelligence in Genomics Market Size Estimation and Forecast by Offering
  • 13.6 Asia-Pacific Artificial Intelligence in Genomics Market Size Estimation and Forecast by Technology
  • 13.7 Asia-Pacific Artificial Intelligence in Genomics Market Size Estimation and Forecast by Delivery Mode
  • 13.8 Asia-Pacific Artificial Intelligence in Genomics Market Size Estimation and Forecast by Functionality
  • 13.9 Asia-Pacific Artificial Intelligence in Genomics Market Size Estimation and Forecast by Application
  • 13.10 Asia-Pacific Artificial Intelligence in Genomics Market Size Estimation and Forecast by End-User
  • 13.11 China Artificial Intelligence in Genomics Market Analysis
  • 13.12 Japan Artificial Intelligence in Genomics Market Analysis
  • 13.13 India Artificial Intelligence in Genomics Market Analysis
  • 13.14 Australia Artificial Intelligence in Genomics Market Analysis
  • 13.15 South Korea Artificial Intelligence in Genomics Market Analysis
  • 13.16 Rest of Asia-Pacific Artificial Intelligence in Genomics Market Analysis

14 Latin America Artificial Intelligence in Genomics Market Analysis

  • 14.1 Key Findings
  • 14.2 Latin America Artificial Intelligence in Genomics Market Attractiveness Index
  • 14.3 Latin America Artificial Intelligence in Genomics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 14.4 Latin America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Country
  • 14.5 Latin America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Offering
  • 14.6 Latin America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Technology
  • 14.7 Latin America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Delivery Mode
  • 14.8 Latin America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Functionality
  • 14.9 Latin America Artificial Intelligence in Genomics Market Size Estimation and Forecast by Application
  • 14.10 Latin America Artificial Intelligence in Genomics Market Size Estimation and Forecast by End-User
  • 14.11 Brazil Artificial Intelligence in Genomics Market Analysis
  • 14.12 Mexico Artificial Intelligence in Genomics Market Analysis
  • 14.13 Rest of Latin America Artificial Intelligence in Genomics Market Analysis

15 MEA Artificial Intelligence in Genomics Market Analysis

  • 15.1 Key Findings
  • 15.2 MEA Artificial Intelligence in Genomics Market Attractiveness Index
  • 15.3 MEA Artificial Intelligence in Genomics Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 15.4 MEA Artificial Intelligence in Genomics Market Size Estimation and Forecast by Country
  • 15.5 MEA Artificial Intelligence in Genomics Market Size Estimation and Forecast by Offering
  • 15.6 MEA Artificial Intelligence in Genomics Market Size Estimation and Forecast by Technology
  • 15.7 MEA Artificial Intelligence in Genomics Market Size Estimation and Forecast by Delivery Mode
  • 15.8 MEA Artificial Intelligence in Genomics Market Size Estimation and Forecast by Functionality
  • 15.9 MEA Artificial Intelligence in Genomics Market Size Estimation and Forecast by Application
  • 15.10 MEA Artificial Intelligence in Genomics Market Size Estimation and Forecast by End-User
  • 15.11 South Africa Artificial Intelligence in Genomics Market Analysis
  • 15.12 GCC Artificial Intelligence in Genomics Market Analysis
  • 15.13 Rest of MEA Artificial Intelligence in Genomics Market Analysis

16 Company Profiles

  • 16.1 Competitive Landscape, 2022
  • 16.2 Strategic Outlook
  • 16.3 IBM
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Financial Analysis
      • 16.3.3.1 Net Revenue, 2017-2022
      • 16.3.3.2 R&D, 2017-2022
      • 16.3.3.3 Regional Market Shares, 2022
    • 16.3.4 Product Benchmarking
  • 16.4 MICROSOFT CORPORATION
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Financial Analysis
      • 16.4.3.1 Net Revenue, 2017-2022
      • 16.4.3.2 R&D, 2017-2022
      • 16.4.3.3 Regional Market Shares, 2022
    • 16.4.4 Product Benchmarking
    • 16.4.5 Strategic Outlook
  • 16.5 NVIDIA CORPORATION
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Financial Analysis
      • 16.5.3.1 Net Revenue, 2018-2023
      • 16.5.3.2 R&D, 2018-2023
      • 16.5.3.3 Regional Market Shares, 2022
    • 16.5.4 Product Benchmarking
    • 16.5.5 Strategic Outlook
  • 16.6 DEEP GENOMICS INCORPORATED
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Product Benchmarking
    • 16.6.4 Strategic Outlook
  • 16.7 FABRIC GENOMICS, INC.
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Product Benchmarking
    • 16.7.4 Strategic Outlook
  • 16.8 DATA4CURE, INC.
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Product Benchmarking
  • 16.9 PREDICTIVE ONCOLOGY INC.
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Financial Analysis
      • 16.9.3.1 Net Revenue, 2017-2022
      • 16.9.3.2 R&D, 2017-2022
    • 16.9.4 Product Benchmarking
    • 16.9.5 Strategic Outlook
  • 16.10 EMEDGENE TECHNOLOGIES LTD
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Product Benchmarking
    • 16.10.4 Strategic Outlook
  • 16.11 CONGENICA LTD.
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Product Benchmarking
    • 16.11.4 Strategic Outlook
  • 16.12 SOPHIA GENETICS SA
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Product Benchmarking
    • 16.12.4 Strategic Outlook
  • 16.13 ILLUMINA INC.
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Financial Analysis
      • 16.13.3.1 Net Revenue, 2017-2022
      • 16.13.3.2 R&D, 2017-2022
      • 16.13.3.3 Regional Market Shares, 2022
    • 16.13.4 Product Benchmarking
    • 16.13.5 Strategic Outlook
  • 16.14 BenevolentAI Limited.
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Product Benchmarking
    • 16.14.4 Strategic Outlook
  • 16.15 Freenome Holdings, Inc
    • 16.15.1 Company Snapshot
    • 16.15.2 Company Overview
    • 16.15.3 Product Benchmarking
    • 16.15.4 Strategic Outlook
  • 16.16 Verge Genomics
    • 16.16.1 Company Snapshot
    • 16.16.2 Company Overview
    • 16.16.3 Product Benchmarking
    • 16.16.4 Strategic Outlook

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks from
  • 17.2 Recommendations for Market Players
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제